Literature DB >> 3109949

Immunoreactive forms of caldesmon in cultivated human vascular smooth muscle cells.

M A Glukhova, A E Kabakov, O I Ornatsky, T D Vasilevskaya, V E Koteliansky, V N Smirnov.   

Abstract

150 kDa caldesmon was shown to be characteristic of vascular smooth muscle cells in normal tissue rather than in subculture. Subcultured smooth muscle cells from human aorta contained only the 70 kDa immunoreactive form of caldesmon. During the course of primary culture the amount of 150 kDa caldesmon as well as metavinculin decreased significantly whilst 70 kDa caldesmon became the predominant form, and by the onset of cell division the 150 kDa form was practically substituted by 70 kDa caldesmon. The data show that the predominance of 150 kDa caldesmon is characteristic of contractile smooth muscle cells, while in proliferating cells 70 kDa caldesmon is expressed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3109949     DOI: 10.1016/0014-5793(87)81064-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  5 in total

Review 1.  The molecular anatomy of caldesmon.

Authors:  S B Marston; C S Redwood
Journal:  Biochem J       Date:  1991-10-01       Impact factor: 3.857

2.  Expression of smooth muscle-specific proteins in myoepithelium and stromal myofibroblasts of normal and malignant human breast tissue.

Authors:  D Lazard; X Sastre; M G Frid; M A Glukhova; J P Thiery; V E Koteliansky
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205

3.  Caldesmon, calponin and alpha-smooth muscle actin expression in subcultured smooth muscle cells from human airways.

Authors:  W Durand-Arczynska; N Marmy; J Durand
Journal:  Histochemistry       Date:  1993-12

4.  Caldesmon mRNA splicing and isoform expression in mammalian smooth-muscle and non-muscle tissues.

Authors:  A M Payne; P Yue; K Pritchard; S B Marston
Journal:  Biochem J       Date:  1995-01-15       Impact factor: 3.857

5.  A 32-nucleotide exon-splicing enhancer regulates usage of competing 5' splice sites in a differential internal exon.

Authors:  M B Humphrey; J Bryan; T A Cooper; S M Berget
Journal:  Mol Cell Biol       Date:  1995-08       Impact factor: 4.272

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.